Keywords: novartis, trileptal, backed, epilepsy, received, approval, usa

Novartis' Trileptal backed for epilepsy

Article | 19 January 2000

Print This

Novartis has received approval in the USA for its anti-epileptic agentTrileptal (oxcarbazepine), which will be launched next month. It is ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in